For three days in the last week of March, the United States Supreme Court heard arguments on the Affordable Care Act. No Federal law in the U.S. in recent memory has aroused such bitter controversy. If it is struck down as unconstitutional, President Barack Obama's prestige will suffer. He is due for re-election in November. Very many think the court will rule against him in June. The core of the law...

The speed and determination with which the Tamil Nadu government has been slapping its citizens right, left and centre with colonial-era laws, it would seem as if a full-fledged war of independence is raging in the fishing villages of Idinthakarai and Kudankulam along the coast of Tamil Nadu. According to findings by a team led senior journalist Sam Rajappa, in just four months between September (when the protest movement against the...

-The Telegraph   The New York Times has reported that Wal-Mart, the US-based retail giant, hushed up an internal investigation sometime after the company was told of a bribery campaign to obtain licences and facilitate rapid expansion in Mexico. Some of the alleged instances of bribery are certain to ring a bell in India where it is not too difficult to bend rules for a price. The New York Times said its “examination...

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...